Clinical next-generation sequencing in patients with non-small cell lung cancer. - Wikidata - awgldk - TriplyDB

Clinical next-generation sequencing in patients with non-small cell lung cancer.

Clinical next-generation sequencing in patients with non-small cell lung cancer.

http://www.wikidata.org/entity/Q54313342

about

ALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncology Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges The possibility of clinical sequencing in the management of cancer Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA Identification of major factors associated with failed clinical molecular oncology testing performed by next generation sequencing (NGS).Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.Utility of different massive parallel sequencing platforms for mutation profiling in clinical samples and identification of pitfalls using FFPE tissue Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA MutAid: Sanger and NGS Based Integrated Pipeline for Mutation Identification, Validation and Annotation in Human Molecular Genetics.Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors.Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies.Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.Experience with targeted next generation sequencing for the care of lung cancer: insights into promises and limitations of genomic oncology in day-to-day practice.DaMold: A data-mining platform for variant annotation and visualization in molecular diagnostics research.Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.High copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients.Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer.Next-generation sequencing in NSCLC and melanoma patients: a cost and budget impact analysis.Comprehensive profiling and quantitation of oncogenic mutations in non small-cell lung carcinoma using single molecule amplification and re-sequencing technology.Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology.Clinical application of amplicon-based next-generation sequencing to therapeutic decision making in lung cancer.Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.FGFR2 Amplification in Colorectal Adenocarcinoma.Massive parallel sequencing of solid tumours - challenges and opportunities for pathologists.A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic Counseling.Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.ALK+ lung adenocarcinoma in never smokers and long-term ex-smokers: prevalence and detection by immunohistochemistry and fluorescence in situ hybridization.Estrogen, Estrogen Receptor and Lung Cancer Estimation of age-related DNA degradation from formalin-fixed and paraffin-embedded tissue according to the extraction methods Discrimination of Germline EGFR T790M Mutations in Plasma Cell-Free DNA Allows Study of Prevalence Across 31,414 Cancer Patients.Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer.

P2860

Q26738387-A299D429-D8C2-4322-87C7-6C58879179FB Q26782324-ED19DF13-94B4-45D6-BDA4-344CAC46AA54 Q28072144-06C8D644-3252-4239-8EC1-1F07DF577470 Q33798605-190907F7-DDAC-4048-AB48-D2AC1AB69725 Q34550417-CA8472E2-E13D-45FA-8B65-BC3FD63673A1 Q35651423-9DCB293E-F02C-4230-8418-CDCCE0436631 Q35662768-6CA456FE-4A03-4789-9399-FC8AFDD84541 Q35664233-A20FB1D4-6163-44D2-BB84-B3AA838834B4 Q35767728-B83235B8-EDD7-4BDC-877D-38D92B869284 Q35810461-44BAB313-27B4-4CBD-B021-BE81A91E5D68 Q35913042-2F4B58D8-526C-485A-8277-151161BF79EF Q35937517-16F0CAC7-DD7D-402A-A1F5-597A170092F0 Q35996102-4A2363FD-701E-4FE1-A4B9-8E9769DA7FC7 Q35998823-E8FFCC53-F059-40F8-B978-98E697F315C1 Q36014165-7A962853-BB26-4EE3-A0FE-01CD0F4BD64E Q36135533-56FCCCB3-34A8-44B8-ABC3-5F746C07BF99 Q36167042-5EA49914-72C2-40AB-95BD-40106BBDAFF1 Q36301400-E830B3E6-BC93-47E6-BC80-E658F85605D5 Q36342845-EBA00943-9806-491C-88DC-BD0C5309D160 Q36355920-78817A9C-4B7E-4B1C-97F3-765CC0E74634 Q36404083-8A30B577-1FEA-4EAD-8405-E4502EF4FAD1 Q36414198-9AEC9746-DF26-4F1D-8B6E-5F044D360189 Q36586155-622C470C-4A11-43D9-A604-C37332D582B5 Q37269473-A11A8E43-5934-4F8F-820D-215F00E90D72 Q37404690-6C2C8E85-429E-4598-BBAE-DBF0551A457F Q37580410-08455873-9F43-418F-AEFA-9B9041A1BF50 Q37736978-0A6A2834-D043-4EAC-A00A-12DD23BCC40E Q38402811-8E05B061-C74B-474F-AAA0-42F564689283 Q38679628-7405493A-D97C-44C9-A6CF-DA564F6ECDE5 Q38694309-78C13F65-6A16-4892-AB4C-14EB8BBE968C Q38828314-B0FA4F74-85D3-4438-AE9C-68CD9EB8A570 Q38850529-F431350B-8096-4CB2-8935-6F3F1C546BE7 Q39244943-8CFF471A-D544-4F45-B69B-880AF8655C01 Q39641416-A5950EF4-2D16-4A35-949F-86F129BFBC97 Q40084048-33990FB2-5C93-46E8-B3C4-08E6D7316725 Q40513502-20EF48BD-A547-42E2-A68F-4DC05E2C4B2D Q41573792-71649F68-8011-4EE9-BC5B-D00A670785AC Q41672200-80B82676-BC30-47DC-AA9E-10B1CA259031 Q46030309-0C2DF08C-9227-497E-9447-4E445DEE51AF Q47162466-4C38EB5C-017C-49A5-966B-BBD8F65766C8

P2860

Clinical next-generation sequencing in patients with non-small cell lung cancer.

http://www.wikidata.org/entity/Q54313342

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Clinical next-generation sequencing in patients with non-small cell lung cancer.

@en

Clinical next-generation sequencing in patients with non-small cell lung cancer.

@nl

type

label

Clinical next-generation sequencing in patients with non-small cell lung cancer.

@en

Clinical next-generation sequencing in patients with non-small cell lung cancer.

@nl

prefLabel

Clinical next-generation sequencing in patients with non-small cell lung cancer.

@en

Clinical next-generation sequencing in patients with non-small cell lung cancer.

@nl

P1433

Q54313342-847F82D1-A6CF-49B7-B448-0E20C3D33089

P1476

Q54313342-CDB2DA72-462E-405A-BD4C-BA3D3DB9B594

P2093

Q54313342-1DB40940-D484-4C65-BD12-E3F5CF620F19

Q54313342-361007BB-89BE-437A-B459-3E774BE23A2B

Q54313342-40AEA81A-FC16-4B01-964B-B5055EA78E24

Q54313342-4B2F135F-B61F-43B4-95DF-F4C1962F74BA

Q54313342-564BF3E5-C8EA-431B-B50B-E087D08969BB

Q54313342-5D3CCEB7-EA98-4EBC-9F15-A960EC943D74

Q54313342-6536A0F6-AD34-4E0C-9879-3DEA975CB971

Q54313342-69D73313-CB0C-46E8-8772-E9191BB95628

Q54313342-6B59347E-1909-4E4E-BD18-94862108F68A

Q54313342-70A29546-958E-4B9B-A944-85F64C3E91A1

P2860

Q54313342-06BB1BD2-3254-442A-9547-A0F212BC2FF3

Q54313342-08251663-C13D-4FA4-9FDE-78C5B38B1AFF

Q54313342-1B1BA00C-991B-407F-81C4-BB0BFEE3752B

Q54313342-2BECFF5A-189B-4B78-8C25-DC8076ADED19

Q54313342-2CACEB93-769E-4FED-817A-8FBD99BC9B3E

Q54313342-2CE00AB7-3A44-4D27-80E0-4A9689636D87

Q54313342-2EBC5DD0-FF2B-421A-8DA1-C03FF4A240F0

Q54313342-3F2330DA-B77B-4A61-9293-7BAFF2AE1B39

Q54313342-56737EC4-A3D3-4BAF-B2EA-C967AAF8913E

Q54313342-5ABA580D-583D-429E-83C4-8766DE1D006E

P304

Q54313342-A50EC319-53D2-49EC-ACA3-48D369566AFD

P31

Q54313342-6F8F8ECD-7108-4064-B7F3-D60EF2733B97

P356

Q54313342-38D44358-8E3D-416D-BF56-A1444B0203BF

P407

Q54313342-F70434FD-0618-409B-B6E0-5FAB319B6BCC

P433

Q54313342-76DC9A7F-564D-40A8-9FEB-87D1194C035F

P478

Q54313342-EE883653-BF03-44A3-9310-2F723FC918D5

P50

Q54313342-3E43A453-50CB-4816-80B4-CEC1B4D9EFB8

Q54313342-6F54426D-C656-4F84-888C-01AEFAF172B2

P577

Q54313342-5BB80538-4DAF-41A2-B874-3BE15E4EE7F9

P5875

Q54313342-BBDB9CEA-FC41-498B-912E-8E119F30B0DA

P698

Q54313342-FA540625-DF72-494A-B189-5D45E5961377

P356

P1433

P1476

Clinical next-generation sequencing in patients with non-small cell lung cancer.

@en

P2093

Andrew J Bredemeyer

http://www.w3.org/2001/XMLSchema#string

Catherine E Cottrell

http://www.w3.org/2001/XMLSchema#string

Daniel Morgensztern

http://www.w3.org/2001/XMLSchema#string

David H Spencer

http://www.w3.org/2001/XMLSchema#string

Eric J Duncavage

http://www.w3.org/2001/XMLSchema#string

Hussam Al-Kateb

http://www.w3.org/2001/XMLSchema#string

John D Pfeifer

http://www.w3.org/2001/XMLSchema#string

Kalin Guebert

http://www.w3.org/2001/XMLSchema#string

Karen Seibert

http://www.w3.org/2001/XMLSchema#string

Maria Baggstrom

http://www.w3.org/2001/XMLSchema#string

P2860

A pilot study using next-generation sequencing in advanced cancers: feasibility and challenges

Somatic mutations affect key pathways in lung adenocarcinoma

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Comprehensive genomic characterization of squamous cell lung cancers.

The Path to Personalized Medicine

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.

Detection of structural DNA variation from next generation sequencing data: a review of informatic approaches.

P304

631-639

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.29089

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Christina M. Lockwood

P577

2014-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267340544

http://www.w3.org/2001/XMLSchema#string

P698

25345567

http://www.w3.org/2001/XMLSchema#string